Annual CFO
-$50.47 M
+$2.01 M+3.83%
30 June 2024
Summary:
MEI Pharma annual cash flow from operations is currently -$50.47 million, with the most recent change of +$2.01 million (+3.83%) on 30 June 2024. During the last 3 years, it has fallen by -$18.51 million (-57.91%). MEIP annual CFO is now -247.33% below its all-time high of $34.26 million, reached on 30 June 2020.MEIP Cash From Operations Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly CFO
-$11.45 M
+$6.55 M+36.39%
30 September 2024
Summary:
MEI Pharma quarterly cash flow from operations is currently -$11.45 million, with the most recent change of +$6.55 million (+36.39%) on 30 September 2024. Over the past year, it has increased by +$7.04 million (+38.08%). MEIP quarterly CFO is now -116.57% below its all-time high of $69.11 million, reached on 30 June 2020.MEIP Quarterly CFO Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM CFO
-$43.43 M
+$7.04 M+13.95%
30 September 2024
Summary:
MEI Pharma TTM cash flow from operations is currently -$43.43 million, with the most recent change of +$7.04 million (+13.95%) on 30 September 2024. Over the past year, it has increased by +$12.76 million (+22.71%). MEIP TTM CFO is now -180.79% below its all-time high of $53.76 million, reached on 31 December 2020.MEIP TTM CFO Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
MEIP Cash From Operations Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +3.8% | +38.1% | +22.7% |
| 3 y3 years | -57.9% | -48.3% | -42.1% |
| 5 y5 years | -71.5% | +18.7% | -41.5% |
MEIP Cash From Operations High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | -57.9% | +3.8% | -291.1% | +38.1% | -42.1% | +29.4% |
| 5 y | 5 years | -247.3% | +3.8% | -116.6% | +38.1% | -180.8% | +29.4% |
| alltime | all time | -247.3% | +3.8% | -116.6% | +38.1% | -180.8% | +29.4% |
MEI Pharma Cash From Operations History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | -$11.45 M(-36.4%) | -$43.43 M(-14.0%) |
| June 2024 | -$50.47 M(-3.8%) | -$18.00 M(+514.7%) | -$50.47 M(+15.3%) |
| Mar 2024 | - | -$2.93 M(-73.5%) | -$43.78 M(-17.4%) |
| Dec 2023 | - | -$11.05 M(-40.2%) | -$52.98 M(-5.7%) |
| Sept 2023 | - | -$18.49 M(+63.6%) | -$56.19 M(+7.1%) |
| June 2023 | -$52.48 M(+7.7%) | -$11.30 M(-6.8%) | -$52.48 M(-7.4%) |
| Mar 2023 | - | -$12.13 M(-15.0%) | -$56.69 M(-7.8%) |
| Dec 2022 | - | -$14.27 M(-3.5%) | -$61.51 M(+10.2%) |
| Sept 2022 | - | -$14.78 M(-4.7%) | -$55.81 M(+14.5%) |
| June 2022 | -$48.75 M(+52.5%) | -$15.50 M(-8.6%) | -$48.75 M(+9.5%) |
| Mar 2022 | - | -$16.95 M(+97.9%) | -$44.50 M(+3.0%) |
| Dec 2021 | - | -$8.57 M(+10.9%) | -$43.19 M(+41.3%) |
| Sept 2021 | - | -$7.72 M(-31.4%) | -$30.57 M(-4.3%) |
| June 2021 | -$31.96 M(-193.3%) | -$11.26 M(-28.1%) | -$31.96 M(-166.0%) |
| Mar 2021 | - | -$15.65 M(-486.3%) | $48.41 M(-10.0%) |
| Dec 2020 | - | $4.05 M(-144.5%) | $53.76 M(+37.0%) |
| Sept 2020 | - | -$9.11 M(-113.2%) | $39.23 M(+14.5%) |
| June 2020 | $34.26 M(-216.4%) | $69.11 M(-771.3%) | $34.26 M(-179.8%) |
| Mar 2020 | - | -$10.29 M(-1.8%) | -$42.92 M(-2.4%) |
| Dec 2019 | - | -$10.48 M(-25.6%) | -$43.97 M(+43.3%) |
| Sept 2019 | - | -$14.08 M(+74.6%) | -$30.68 M(+4.3%) |
| June 2019 | -$29.42 M(+39.9%) | -$8.06 M(-28.9%) | -$29.42 M(+18.4%) |
| Mar 2019 | - | -$11.34 M(-505.2%) | -$24.84 M(+25.9%) |
| Dec 2018 | - | $2.80 M(-121.8%) | -$19.74 M(-27.7%) |
| Sept 2018 | - | -$12.82 M(+268.0%) | -$27.29 M(+29.7%) |
| June 2018 | -$21.04 M(-703.4%) | -$3.48 M(-44.2%) | -$21.04 M(+1.6%) |
| Mar 2018 | - | -$6.24 M(+31.3%) | -$20.70 M(+61.0%) |
| Dec 2017 | - | -$4.75 M(-27.6%) | -$12.85 M(+8.5%) |
| Sept 2017 | - | -$6.56 M(+108.6%) | -$11.85 M(-439.9%) |
| June 2017 | $3.49 M(-119.5%) | -$3.15 M(-295.9%) | $3.49 M(+10.7%) |
| Mar 2017 | - | $1.61 M(-142.9%) | $3.15 M(-210.8%) |
| Dec 2016 | - | -$3.75 M(-142.7%) | -$2.84 M(-14.5%) |
| Sept 2016 | - | $8.77 M(-351.9%) | -$3.32 M(-81.4%) |
| June 2016 | -$17.86 M(-36.4%) | -$3.48 M(-20.6%) | -$17.86 M(-15.4%) |
| Mar 2016 | - | -$4.38 M(+3.7%) | -$21.12 M(-15.1%) |
| Dec 2015 | - | -$4.23 M(-26.6%) | -$24.88 M(-8.2%) |
| Sept 2015 | - | -$5.76 M(-14.6%) | -$27.10 M(-3.5%) |
| June 2015 | -$28.07 M(+44.3%) | -$6.74 M(-17.3%) | -$28.07 M(+3.3%) |
| Mar 2015 | - | -$8.15 M(+26.4%) | -$27.18 M(+12.8%) |
| Dec 2014 | - | -$6.45 M(-4.2%) | -$24.10 M(+9.0%) |
| Sept 2014 | - | -$6.73 M(+15.1%) | -$22.12 M(+13.7%) |
| June 2014 | -$19.45 M | -$5.85 M(+15.4%) | -$19.45 M(+18.8%) |
| Mar 2014 | - | -$5.07 M(+13.5%) | -$16.37 M(+17.5%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2013 | - | -$4.47 M(+9.9%) | -$13.93 M(+19.9%) |
| Sept 2013 | - | -$4.06 M(+46.9%) | -$11.62 M(+15.7%) |
| June 2013 | -$10.04 M(+41.8%) | -$2.77 M(+5.1%) | -$10.04 M(+17.0%) |
| Mar 2013 | - | -$2.63 M(+21.8%) | -$8.58 M(+4.4%) |
| Dec 2012 | - | -$2.16 M(-13.1%) | -$8.22 M(+4.9%) |
| Sept 2012 | - | -$2.49 M(+90.7%) | -$7.84 M(+10.7%) |
| June 2012 | -$7.08 M(+8.9%) | -$1.30 M(-42.6%) | -$7.08 M(-4.5%) |
| Mar 2012 | - | -$2.27 M(+28.1%) | -$7.41 M(+8.2%) |
| Dec 2011 | - | -$1.77 M(+2.5%) | -$6.85 M(+1.8%) |
| Sept 2011 | - | -$1.73 M(+5.9%) | -$6.73 M(+3.5%) |
| June 2011 | -$6.50 M(-35.2%) | -$1.63 M(-4.5%) | -$6.50 M(-9.4%) |
| Mar 2011 | - | -$1.71 M(+3.6%) | -$7.17 M(+3.4%) |
| Dec 2010 | - | -$1.65 M(+9.8%) | -$6.94 M(-10.0%) |
| Sept 2010 | - | -$1.50 M(-34.8%) | -$7.70 M(-23.2%) |
| June 2010 | -$10.03 M(-4.9%) | -$2.31 M(+56.6%) | -$10.03 M(-15.1%) |
| Mar 2010 | - | -$1.47 M(-39.1%) | -$11.81 M(-3.0%) |
| Dec 2009 | - | -$2.42 M(-36.9%) | -$12.18 M(+4.4%) |
| Sept 2009 | - | -$3.83 M(-6.1%) | -$11.66 M(+10.5%) |
| June 2009 | -$10.55 M(-8.2%) | -$4.08 M(+122.4%) | -$10.55 M(+10.3%) |
| Mar 2009 | - | -$1.84 M(-3.6%) | -$9.57 M(-15.7%) |
| Dec 2008 | - | -$1.91 M(-30.1%) | -$11.35 M(-3.7%) |
| Sept 2008 | - | -$2.73 M(-12.1%) | -$11.79 M(+2.6%) |
| June 2008 | -$11.50 M(+6.6%) | -$3.10 M(-14.3%) | -$11.50 M(+9.7%) |
| Mar 2008 | - | -$3.62 M(+54.0%) | -$10.48 M(+19.4%) |
| Dec 2007 | - | -$2.35 M(-3.5%) | -$8.78 M(+23.7%) |
| Sept 2007 | - | -$2.43 M(+16.5%) | -$7.10 M(-34.2%) |
| June 2007 | -$10.79 M(+18.7%) | -$2.09 M(+9.2%) | -$10.79 M(-5.5%) |
| Mar 2007 | - | -$1.91 M(+188.0%) | -$11.41 M(-20.6%) |
| Dec 2006 | - | -$664.00 K(-89.2%) | -$14.37 M(-0.2%) |
| Sept 2006 | - | -$6.12 M(+125.6%) | -$14.39 M(+58.4%) |
| June 2006 | -$9.09 M(+62.9%) | -$2.71 M(-44.3%) | -$9.09 M(+23.4%) |
| Mar 2006 | - | -$4.87 M(+609.2%) | -$7.37 M(+37.2%) |
| Dec 2005 | - | -$687.00 K(-15.8%) | -$5.37 M(+0.2%) |
| Sept 2005 | - | -$816.00 K(-17.8%) | -$5.36 M(-4.0%) |
| June 2005 | -$5.58 M(-30.0%) | -$993.00 K(-65.5%) | -$5.58 M(+5.0%) |
| Mar 2005 | - | -$2.88 M(+325.3%) | -$5.32 M(-35.2%) |
| Dec 2004 | - | -$676.00 K(-34.8%) | -$8.20 M(-0.7%) |
| Sept 2004 | - | -$1.04 M(+42.4%) | -$8.26 M(+3.6%) |
| June 2004 | -$7.97 M(+333.0%) | -$728.00 K(-87.4%) | -$7.97 M(+10.0%) |
| Mar 2004 | - | -$5.76 M(+683.3%) | -$7.24 M(+387.2%) |
| Dec 2003 | - | -$735.00 K(-2.3%) | -$1.49 M(+97.7%) |
| Sept 2003 | - | -$752.00 K | -$752.00 K |
| June 2003 | -$1.84 M | - | - |
FAQ
- What is MEI Pharma annual cash flow from operations?
- What is the all time high annual CFO for MEI Pharma?
- What is MEI Pharma annual CFO year-on-year change?
- What is MEI Pharma quarterly cash flow from operations?
- What is the all time high quarterly CFO for MEI Pharma?
- What is MEI Pharma quarterly CFO year-on-year change?
- What is MEI Pharma TTM cash flow from operations?
- What is the all time high TTM CFO for MEI Pharma?
- What is MEI Pharma TTM CFO year-on-year change?
What is MEI Pharma annual cash flow from operations?
The current annual CFO of MEIP is -$50.47 M
What is the all time high annual CFO for MEI Pharma?
MEI Pharma all-time high annual cash flow from operations is $34.26 M
What is MEI Pharma annual CFO year-on-year change?
Over the past year, MEIP annual cash flow from operations has changed by +$2.01 M (+3.83%)
What is MEI Pharma quarterly cash flow from operations?
The current quarterly CFO of MEIP is -$11.45 M
What is the all time high quarterly CFO for MEI Pharma?
MEI Pharma all-time high quarterly cash flow from operations is $69.11 M
What is MEI Pharma quarterly CFO year-on-year change?
Over the past year, MEIP quarterly cash flow from operations has changed by +$7.04 M (+38.08%)
What is MEI Pharma TTM cash flow from operations?
The current TTM CFO of MEIP is -$43.43 M
What is the all time high TTM CFO for MEI Pharma?
MEI Pharma all-time high TTM cash flow from operations is $53.76 M
What is MEI Pharma TTM CFO year-on-year change?
Over the past year, MEIP TTM cash flow from operations has changed by +$12.76 M (+22.71%)